J Cassidy
- Hematology top 1%
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 22
- Cancer Treatment and Pharmacology 19
- Colorectal Cancer Surgical Treatments 8
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 5
- Speech and Hearing top 1%
- Rheumatology top 2%
-
- Cancer therapeutics and mechanisms 8
- Biochemical and Molecular Research 5
-
- Immunodeficiency and Autoimmune Disorders 6
-
- Genetic factors in colorectal cancer 5
- Co-authors
- Chris TwelvesJuan BassVirgil HansonJane G. SchallerJohn BaumJoseph E. LevinsonEarl J. BrewerStan B. Kaye
- Cited by
- HematologyOncologyBiomaterials
- Journals
- British Journal of Cancer (16 papers)European Journal of Cancer (6 papers)Journal of Clinical Oncology (6 papers)
- Partner nations
- United KingdomUnited StatesIsrael
In The Last Decade
J Cassidy
77 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Hematology 833
- Oncology 1.7k
- Biomaterials 549
- Speech and Hearing 254
- Rheumatology 521
Countries citing papers authored by J Cassidy
This map shows the geographic impact of J Cassidy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Cassidy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Cassidy more than expected).
Fields of papers citing papers by J Cassidy
This network shows the impact of papers produced by J Cassidy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Cassidy. The network helps show where J Cassidy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J Cassidy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2023 | 4 | |
| 4 | 2011 | 349 | |
| 5 | 2011 | 49 | |
| 6 | 2011 | 178 | |
| 7 | 2010 | 9 | |
| 8 | 2009 | 121 | |
| 9 | 2006 | 221 | |
| 10 | 2005 | 26 | |
| 11 | 2004 | 92 | |
| 12 | 2003 | 35 | |
| 13 | Long-term follow-up confirms a survival advantage of paclitaxel-cisplatin (CP) regimen over the cyclophosphamide-cisplatin (CP) combination in advanced ovarian cancer | 2002 | 5 |
| 14 | 2002 | 88 | |
| 15 | 1998 | 75 | |
| 16 | 1998 | 20 | |
| 17 | 1998 | 10 | |
| 18 | 1996 | 103 | |
| 19 | 1990 | 11 | |
| 20 | 1989 | 4 |
About J Cassidy
J Cassidy is a scholar working on Oncology, Family Practice, Reproductive Medicine, Pathology and Forensic Medicine and Rheumatology, having authored 79 papers that have together received 4.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (22 papers), Cancer Treatment and Pharmacology (19 papers), Colorectal Cancer Surgical Treatments (8 papers), Cancer therapeutics and mechanisms (8 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Biochemical and Molecular Research (5 papers), Nanoparticle-Based Drug Delivery (5 papers) and Genetic factors in colorectal cancer (5 papers). The work is most often cited by research in Hematology (833 citations), Oncology (1.7k citations), Biomaterials (549 citations), Speech and Hearing (254 citations) and Rheumatology (521 citations). J Cassidy has collaborated with scholars based in United Kingdom, United States and Israel. Frequent co-authors include Chris Twelves, Juan Bass, Virgil Hanson, Jane G. Schaller, John Baum, Joseph E. Levinson, Earl J. Brewer, Stan B. Kaye, Daniela Fraier and J. Sydney Stillman. Their work appears in journals such as British Journal of Cancer, European Journal of Cancer, Journal of Clinical Oncology, Annals of Oncology and Journal of Glaucoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.